[HTML][HTML] Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis

YJ Lin, M Anzaghe, S Schülke - Cells, 2020 - mdpi.com
Rheumatoid arthritis (RA) is an autoimmune disease that involves multiple joints bilaterally.
It is characterized by an inflammation of the tendon (tenosynovitis) resulting in both cartilage …

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection

A Copaescu, O Smibert, A Gibson, EJ Phillips… - Journal of Allergy and …, 2020 - Elsevier
The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome
coronavirus 2 presents with a spectrum of clinical manifestations from asymptomatic or mild …

Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia

R Capra, N De Rossi, F Mattioli, G Romanelli… - European journal of …, 2020 - Elsevier
Background Pneumonia with respiratory failure represents the main cause of death in
COVID-19, where hyper inflammation plays an important role in lung damage. This study …

Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?

S Antinori, C Bonazzetti, G Gubertini, A Capetti… - Autoimmunity …, 2020 - ncbi.nlm.nih.gov
We have read with interest the excellent review by McGonagle et al. discussing the possible
role of hyperinflammation secondary to macrophage activation syndrome (MAS) or cytokine …

[HTML][HTML] Strategies to target ADAM17 in disease: from its discovery to the iRhom revolution

M Calligaris, D Cuffaro, S Bonelli, DP Spanò… - Molecules, 2021 - mdpi.com
For decades, disintegrin and metalloproteinase 17 (ADAM17) has been the object of deep
investigation. Since its discovery as the tumor necrosis factor convertase, it has been …

[HTML][HTML] Early use of low dose tocilizumab in patients with COVID-19: a retrospective cohort study with a complete follow-up

N De Rossi, C Scarpazza, C Filippini, C Cordioli… - …, 2020 - thelancet.com
Background Pneumonia with severe respiratory failure represents the principal cause of
death in COVID-19, where hyper-inflammation plays an important role in lung damage. An …

Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection

S Keam, D Megawati, SK Patel, R Tiwari… - Reviews in Medical …, 2020 - Wiley Online Library
The outbreak of coronavirus disease 2019 (COVID‐19) and pandemic, caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has become a major concern …

[HTML][HTML] The complex role of C-reactive protein in systemic lupus erythematosus

H Enocsson, J Karlsson, HY Li, Y Wu, I Kushner… - Journal of Clinical …, 2021 - mdpi.com
C-reactive protein (CRP) is well-known as a sensitive albeit unspecific biomarker of
inflammation. In most rheumatic conditions, the level of this evolutionarily highly conserved …

Transforming clinical trials in rheumatology: towards patient-centric precision medicine

C Pitzalis, EHS Choy, MH Buch - Nature Reviews Rheumatology, 2020 - nature.com
Despite the success of targeted therapies in the treatment of inflammatory arthritides, the
lack of predictive biomarkers drives a 'trial and error'approach to treatment allocation …

[HTML][HTML] Anti-inflammatory effect of muscle-derived interleukin-6 and its involvement in lipid metabolism

H Nara, R Watanabe - International journal of molecular sciences, 2021 - mdpi.com
Interleukin (IL)-6 has been studied since its discovery for its role in health and diseases. It is
one of the most important pro-inflammatory cytokines. IL-6 was reported as an exacerbating …